Header Logo

Connection

HASHEM EL-SERAG to Middle Aged

Back to Details
This is a "connection" page, showing publications HASHEM EL-SERAG has written about Middle Aged.
HASHEM EL-SERAG
Connection Strength
5.796
Middle Aged
  1. Risk of Hepatocellular Cancer in U.S. Patients With Compensated Cirrhosis Treated With Direct-Acting Antivirals Versus Interferon. Aliment Pharmacol Ther. 2025 Apr; 61(7):1226-1237.
    View in: PubMed
    Score: 0.059
  2. Serum levels of total bile acids are associated with an increased risk of HCC in patients with cirrhosis. Hepatol Commun. 2024 Nov 01; 8(11).
    View in: PubMed
    Score: 0.058
  3. HES V2.0 outperforms GALAD for detection of HCC: A phase 3 biomarker study in the United States. Hepatology. 2025 Feb 01; 81(2):465-475.
    View in: PubMed
    Score: 0.057
  4. PNPLA3, Obesity, and Heavy Alcohol Use in Cirrhosis Patients May Exert a Synergistic Increase Hepatocellular Carcinoma Risk. Clin Gastroenterol Hepatol. 2024 Sep; 22(9):1858-1866.e4.
    View in: PubMed
    Score: 0.056
  5. An Electronic Health Record Model for Predicting Risk of Hepatic Fibrosis in Primary Care Patients. Dig Dis Sci. 2024 Jul; 69(7):2430-2436.
    View in: PubMed
    Score: 0.056
  6. Association of Diet Quality with Metabolic (Dysfunction) Associated Fatty Liver Disease in Veterans in Primary Care. Nutrients. 2023 Jun 01; 15(11).
    View in: PubMed
    Score: 0.053
  7. Risk Stratification Model for Hepatocellular Cancer in Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2023 12; 21(13):3296-3304.e3.
    View in: PubMed
    Score: 0.053
  8. Risk stratification for hepatocellular cancer among patients with cirrhosis using a hepatic fat polygenic risk score. PLoS One. 2023; 18(2):e0282309.
    View in: PubMed
    Score: 0.052
  9. Risk factors for HCC in contemporary cohorts of patients with cirrhosis. Hepatology. 2023 03 01; 77(3):997-1005.
    View in: PubMed
    Score: 0.052
  10. The Prevalence and Determinants of NAFLD and MAFLD and Their Severity in the VA Primary Care Setting. Clin Gastroenterol Hepatol. 2023 05; 21(5):1252-1260.e5.
    View in: PubMed
    Score: 0.050
  11. Magnitude of and prediction for risk of hepatocellular carcinoma in patients with chronic hepatitis B taking entecavir or tenofovir therapy: A systematic review. J Gastroenterol Hepatol. 2020 Oct; 35(10):1684-1693.
    View in: PubMed
    Score: 0.043
  12. Texas Has the Highest Hepatocellular Carcinoma Incidence Rates in the USA. Dig Dis Sci. 2021 03; 66(3):912-916.
    View in: PubMed
    Score: 0.043
  13. Risk Factors for Cirrhosis in Contemporary Hepatology Practices-Findings From the Texas Hepatocellular Carcinoma Consortium Cohort. Gastroenterology. 2020 07; 159(1):376-377.
    View in: PubMed
    Score: 0.042
  14. Effect of Metabolic Traits on the Risk of Cirrhosis and Hepatocellular Cancer in Nonalcoholic Fatty Liver Disease. Hepatology. 2020 03; 71(3):808-819.
    View in: PubMed
    Score: 0.042
  15. Long-Term Risk of Hepatocellular Carcinoma in HCV Patients Treated With Direct Acting Antiviral Agents. Hepatology. 2020 01; 71(1):44-55.
    View in: PubMed
    Score: 0.041
  16. The effects of sustained virological response to direct-acting anti-viral therapy on the risk of extrahepatic manifestations of hepatitis C infection. Aliment Pharmacol Ther. 2019 06; 49(11):1442-1447.
    View in: PubMed
    Score: 0.040
  17. Statin Use After Diagnosis of Hepatocellular Carcinoma Is Associated With Decreased Mortality. Clin Gastroenterol Hepatol. 2019 09; 17(10):2117-2125.e3.
    View in: PubMed
    Score: 0.039
  18. Validation of the Hepatocellular Carcinoma Early Detection Screening (HES) Algorithm in a Cohort of Veterans With Cirrhosis. Clin Gastroenterol Hepatol. 2019 08; 17(9):1886-1893.e5.
    View in: PubMed
    Score: 0.039
  19. Changing Trends in Colorectal Cancers (Detected by Screening, During Screening Intervals, or Associated With Nonadherence) Identify Possible Health Care System Quality Measures. Gastroenterology. 2019 02; 156(3):809-811.
    View in: PubMed
    Score: 0.038
  20. Epidemiology and Management of Hepatocellular Carcinoma. Gastroenterology. 2019 01; 156(2):477-491.e1.
    View in: PubMed
    Score: 0.038
  21. Ancestry and Risk of Hepatic Fibrosis and Inflammation in Patients With HCV Infection. Clin Gastroenterol Hepatol. 2019 08; 17(9):1912-1914.
    View in: PubMed
    Score: 0.038
  22. Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease. Gastroenterology. 2018 12; 155(6):1828-1837.e2.
    View in: PubMed
    Score: 0.038
  23. Temporal trend and risk determinants of hepatocellular carcinoma in chronic hepatitis B patients on entecavir or tenofovir. J Viral Hepat. 2018 05; 25(5):543-551.
    View in: PubMed
    Score: 0.037
  24. Evaluating screening approaches for hepatocellular carcinoma in a cohort of HCV related cirrhosis patients from the Veteran's Affairs Health Care System. BMC Med Res Methodol. 2018 01 04; 18(1):1.
    View in: PubMed
    Score: 0.036
  25. Lessons From Using Culture-Guided Treatment After Referral for Multiple Treatment Failures for Helicobacter pylori Infection. Clin Gastroenterol Hepatol. 2018 09; 16(9):1531-1532.
    View in: PubMed
    Score: 0.036
  26. Low-fat Dietary Pattern and Pancreatic Cancer Risk in the Women's Health Initiative Dietary Modification Randomized Controlled Trial. J Natl Cancer Inst. 2018 01 01; 110(1).
    View in: PubMed
    Score: 0.036
  27. Factors That Contribute to Indeterminate Results From the?QuantiFERON-TB Gold In-Tube Test in Patients With?Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2018 10; 16(10):1616-1621.e1.
    View in: PubMed
    Score: 0.036
  28. Advances in the management of hepatocellular carcinoma. Clin Adv Hematol Oncol. 2017 Aug; 15 Suppl 9(8):2-6.
    View in: PubMed
    Score: 0.035
  29. Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents. Gastroenterology. 2017 10; 153(4):996-1005.e1.
    View in: PubMed
    Score: 0.035
  30. Trends in 30-Day and 1-Year Mortality Among Patients Hospitalized With Cirrhosis From 2004 to 2013. Am J Gastroenterol. 2017 Aug; 112(8):1287-1297.
    View in: PubMed
    Score: 0.035
  31. External Validation of the Michigan Barrett's Esophagus Prediction Tool. Clin Gastroenterol Hepatol. 2017 07; 15(7):1124-1126.
    View in: PubMed
    Score: 0.034
  32. The Annual Risk of Esophageal Adenocarcinoma Does Not Decrease Over Time in Patients With Barrett's Esophagus. Am J Gastroenterol. 2017 Jul; 112(7):1049-1055.
    View in: PubMed
    Score: 0.034
  33. Clinical Manifestations of Helicobacter pylori-Negative Gastritis. Clin Gastroenterol Hepatol. 2017 Jul; 15(7):1037-1046.e3.
    View in: PubMed
    Score: 0.034
  34. Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012. Gastroenterology. 2017 03; 152(4):812-820.e5.
    View in: PubMed
    Score: 0.034
  35. Prevalence of Celiac Disease Among Unsuspected Patients Presenting to Open Access Endoscopy. Clin Gastroenterol Hepatol. 2017 01; 15(1):137-139.
    View in: PubMed
    Score: 0.033
  36. Natural History of Untreated Hepatocellular Carcinoma in a US Cohort and the Role of Cancer Surveillance. Clin Gastroenterol Hepatol. 2017 02; 15(2):273-281.e1.
    View in: PubMed
    Score: 0.033
  37. Early outpatient follow-up and 30-day outcomes in patients hospitalized with cirrhosis. Hepatology. 2016 08; 64(2):569-81.
    View in: PubMed
    Score: 0.032
  38. Risk of hepatocellular carcinoma after sustained virological response in Veterans with hepatitis C virus infection. Hepatology. 2016 07; 64(1):130-7.
    View in: PubMed
    Score: 0.032
  39. Epidemiology and outcomes of hepatitis C infection in elderly US Veterans. J Viral Hepat. 2016 09; 23(9):687-96.
    View in: PubMed
    Score: 0.032
  40. The Updated Model: An Adjusted Serum Alpha-Fetoprotein-Based Algorithm for Hepatocellular Carcinoma Detection With Hepatitis C Virus-Related Cirrhosis. Gastroenterology. 2015 Dec; 149(7):1986-7.
    View in: PubMed
    Score: 0.031
  41. Surveillance endoscopy is associated with improved outcomes of oesophageal adenocarcinoma detected in patients with Barrett's oesophagus. Gut. 2016 08; 65(8):1252-60.
    View in: PubMed
    Score: 0.031
  42. Trends in the Burden of Nonalcoholic Fatty Liver Disease in a United States Cohort of Veterans. Clin Gastroenterol Hepatol. 2016 Feb; 14(2):301-8.e1-2.
    View in: PubMed
    Score: 0.031
  43. Prevalence of Barrett's Esophagus in Asian Countries: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2015 Nov; 13(11):1907-18.
    View in: PubMed
    Score: 0.031
  44. Statin use reduces risk of esophageal adenocarcinoma in US veterans with Barrett's esophagus: a nested case-control study. Gastroenterology. 2015 Nov; 149(6):1392-8.
    View in: PubMed
    Score: 0.031
  45. Assessment of disease specific knowledge and health-related quality of life among United States military veterans with inflammatory bowel disease. World J Gastroenterol. 2015 May 21; 21(19):6001-7.
    View in: PubMed
    Score: 0.030
  46. Metabolic syndrome and the risk of Barrett's oesophagus in white males. Aliment Pharmacol Ther. 2015 Jun; 41(11):1182-9.
    View in: PubMed
    Score: 0.030
  47. Coffee and Caffeine Are Associated With Decreased Risk of Advanced Hepatic Fibrosis Among Patients With Hepatitis C. Clin Gastroenterol Hepatol. 2015 Aug; 13(8):1521-31.e3.
    View in: PubMed
    Score: 0.030
  48. The Prevalence of Helicobacter pylori Remains High in African American and Hispanic Veterans. Helicobacter. 2015 Aug; 20(4):305-15.
    View in: PubMed
    Score: 0.030
  49. Genetic Variants in Interleukin-28B Are Associated with Diabetes and Diabetes-Related Complications in Patients with Chronic Hepatitis C Virus Infection. Dig Dis Sci. 2015 Jul; 60(7):2030-7.
    View in: PubMed
    Score: 0.030
  50. Risk factors for Barrett's esophagus compared between African Americans and non-Hispanic Whites. Am J Gastroenterol. 2014 Dec; 109(12):1870-80.
    View in: PubMed
    Score: 0.029
  51. The incidence of esophageal adenocarcinoma in a national veterans cohort with Barrett's esophagus. Am J Gastroenterol. 2014 Dec; 109(12):1862-8; quiz 1861, 1869.
    View in: PubMed
    Score: 0.029
  52. Esophageal COX-2 expression is increased in Barrett's esophagus, obesity, and smoking. Dig Dis Sci. 2015 Jan; 60(1):65-73.
    View in: PubMed
    Score: 0.029
  53. Racial differences in the progression to cirrhosis and hepatocellular carcinoma in HCV-infected veterans. Am J Gastroenterol. 2014 Sep; 109(9):1427-35.
    View in: PubMed
    Score: 0.029
  54. Risk of upper gastrointestinal cancers in patients with gastroesophageal reflux disease after a negative screening endoscopy. Clin Gastroenterol Hepatol. 2015 Feb; 13(2):280-6.
    View in: PubMed
    Score: 0.029
  55. HCV genotype 3 is associated with an increased risk of cirrhosis and hepatocellular cancer in a national sample of U.S. Veterans with HCV. Hepatology. 2014 Jul; 60(1):98-105.
    View in: PubMed
    Score: 0.028
  56. Statin use is associated with a decreased risk of Barrett's esophagus. Gastroenterology. 2014 Aug; 147(2):314-23.
    View in: PubMed
    Score: 0.028
  57. Nonsteroidal anti-inflammatory drugs and the risk of Barrett's esophagus. Clin Gastroenterol Hepatol. 2014 Nov; 12(11):1832-9.e6.
    View in: PubMed
    Score: 0.028
  58. Brief report: the length of newly diagnosed Barrett's esophagus may be decreasing. Dis Esophagus. 2015 Jul; 28(5):418-21.
    View in: PubMed
    Score: 0.028
  59. Use and yield of endoscopy in patients with uncomplicated gastroesophageal reflux disorder. JAMA Intern Med. 2014 Mar; 174(3):462-5.
    View in: PubMed
    Score: 0.028
  60. Personal and family history of cancer and the risk of Barrett's esophagus in men. Dis Esophagus. 2015 Apr; 28(3):283-90.
    View in: PubMed
    Score: 0.028
  61. A new laboratory-based algorithm to predict development of hepatocellular carcinoma in patients with hepatitis C and cirrhosis. Gastroenterology. 2014 May; 146(5):1249-55.e1.
    View in: PubMed
    Score: 0.028
  62. A multibiomarker risk score helps predict risk for Barrett's esophagus. Clin Gastroenterol Hepatol. 2014 Aug; 12(8):1267-71.
    View in: PubMed
    Score: 0.027
  63. Barrett's esophagus suspected at endoscopy but no specialized intestinal metaplasia on biopsy, what's next? Am J Gastroenterol. 2014 Feb; 109(2):178-82.
    View in: PubMed
    Score: 0.027
  64. Poor sleep quality and obstructive sleep apnea in patients with GERD and Barrett's esophagus. Neurogastroenterol Motil. 2014 Mar; 26(3):346-52.
    View in: PubMed
    Score: 0.027
  65. No significant effects of smoking or alcohol consumption on risk of Barrett's esophagus. Dig Dis Sci. 2014 Jan; 59(1):108-16.
    View in: PubMed
    Score: 0.027
  66. Many patients with interleukin 28B genotypes associated with response to therapy are ineligible for treatment because of comorbidities. Clin Gastroenterol Hepatol. 2014 Feb; 12(2):327-333.e1.
    View in: PubMed
    Score: 0.027
  67. Dietary consumption of meat, fat, animal products and advanced glycation end-products and the risk of Barrett's oesophagus. Aliment Pharmacol Ther. 2013 Oct; 38(7):817-24.
    View in: PubMed
    Score: 0.027
  68. Circulating inflammatory cytokines and adipokines are associated with increased risk of Barrett's esophagus: a case-control study. Clin Gastroenterol Hepatol. 2014 Feb; 12(2):229-238.e3.
    View in: PubMed
    Score: 0.027
  69. Oral bisphosphonates and the risk of Barrett's esophagus: case-control analysis of US veterans. Am J Gastroenterol. 2013 Oct; 108(10):1576-83.
    View in: PubMed
    Score: 0.027
  70. Dietary fructose intake and severity of liver disease in hepatitis C virus-infected patients. J Clin Gastroenterol. 2013 Jul; 47(6):545-52.
    View in: PubMed
    Score: 0.027
  71. Prevalence and predictors of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients. Hepatology. 2013 Aug; 58(2):538-45.
    View in: PubMed
    Score: 0.027
  72. The association between serological and dietary vitamin D levels and hepatitis C-related liver disease risk differs in African American and white males. Aliment Pharmacol Ther. 2013 Jul; 38(1):28-37.
    View in: PubMed
    Score: 0.026
  73. Age at onset of GERD symptoms predicts risk of Barrett's esophagus. Am J Gastroenterol. 2013 Jun; 108(6):915-22.
    View in: PubMed
    Score: 0.026
  74. The incidence and prevalence of inflammatory bowel disease among U.S. veterans: a national cohort study. Inflamm Bowel Dis. 2013 Apr; 19(5):1059-64.
    View in: PubMed
    Score: 0.026
  75. Referral and receipt of treatment for hepatocellular carcinoma in United States veterans: effect of patient and nonpatient factors. Hepatology. 2013 May; 57(5):1858-68.
    View in: PubMed
    Score: 0.026
  76. CDC and USPSTF 2012 recommendations for screening for hepatitis C virus infection: overview and take-home messages. Clin Gastroenterol Hepatol. 2013 Mar; 11(3):200-3.
    View in: PubMed
    Score: 0.026
  77. The prevalence of oesophageal eosinophilia and eosinophilic oesophagitis: a prospective study in unselected patients presenting to endoscopy. Aliment Pharmacol Ther. 2013 Apr; 37(8):825-32.
    View in: PubMed
    Score: 0.026
  78. Dietary intake of vegetables, folate, and antioxidants and the risk of Barrett's esophagus. Cancer Causes Control. 2013 May; 24(5):1005-14.
    View in: PubMed
    Score: 0.026
  79. Visceral abdominal obesity measured by CT scan is associated with an increased risk of Barrett's oesophagus: a case-control study. Gut. 2014 Feb; 63(2):220-9.
    View in: PubMed
    Score: 0.026
  80. Occupational exposure and the risk of Barrett's esophagus: a case-control study. Dig Dis Sci. 2013 Jul; 58(7):1967-75.
    View in: PubMed
    Score: 0.026
  81. Sleep duration and incidence of colorectal cancer in postmenopausal women. Br J Cancer. 2013 Jan 15; 108(1):213-21.
    View in: PubMed
    Score: 0.026
  82. Waist-to-hip ratio, but not body mass index, is associated with an increased risk of Barrett's esophagus in white men. Clin Gastroenterol Hepatol. 2013 Apr; 11(4):373-381.e1.
    View in: PubMed
    Score: 0.026
  83. Helicobacter pylori-negative gastritis: prevalence and risk factors. Am J Gastroenterol. 2013 Jan; 108(1):65-71.
    View in: PubMed
    Score: 0.025
  84. Automated identification of surveillance colonoscopy in inflammatory bowel disease using natural language processing. Dig Dis Sci. 2013 Apr; 58(4):936-41.
    View in: PubMed
    Score: 0.025
  85. Myelosuppression monitoring after immunomodulator initiation in veterans with inflammatory bowel disease: a national practice audit. Aliment Pharmacol Ther. 2012 Dec; 36(11-12):1049-56.
    View in: PubMed
    Score: 0.025
  86. Racial differences in the association between adiposity measures and the risk of hepatitis C-related liver disease. J Clin Gastroenterol. 2012 Oct; 46(9):779-88.
    View in: PubMed
    Score: 0.025
  87. Practice patterns of surveillance endoscopy in a Veterans Affairs database of 29,504 patients with Barrett's esophagus. Gastrointest Endosc. 2012 Oct; 76(4):743-55.
    View in: PubMed
    Score: 0.025
  88. Postreferral colonoscopy delays in diagnosis of colorectal cancer: a mixed-methods analysis. Qual Manag Health Care. 2012 Oct-Dec; 21(4):252-61.
    View in: PubMed
    Score: 0.025
  89. Patient-centered, comparative effectiveness of esophageal cancer screening: protocol for a comparative effectiveness research study to inform guidelines for evidence-based approach to screening and surveillance endoscopy. BMC Health Serv Res. 2012 Aug 28; 12:288.
    View in: PubMed
    Score: 0.025
  90. Human papillomavirus and the risk of Barrett's esophagus. Dis Esophagus. 2013 Jul; 26(5):517-21.
    View in: PubMed
    Score: 0.025
  91. Finasteride and methadone use and risk of advanced hepatitis C related liver disease. Dig Dis Sci. 2012 Nov; 57(11):3004-10.
    View in: PubMed
    Score: 0.025
  92. Higher serum testosterone is associated with increased risk of advanced hepatitis C-related liver disease in males. Hepatology. 2012 Mar; 55(3):759-68.
    View in: PubMed
    Score: 0.024
  93. Determinants of serum alpha-fetoprotein levels in hepatitis C-infected patients. Clin Gastroenterol Hepatol. 2012 Apr; 10(4):428-33.
    View in: PubMed
    Score: 0.024
  94. Risk of colorectal cancer among Caucasian and African American veterans with ulcerative colitis. Inflamm Bowel Dis. 2012 Jun; 18(6):1011-7.
    View in: PubMed
    Score: 0.023
  95. Level of a-fetoprotein predicts mortality among patients with hepatitis C-related hepatocellular carcinoma. Clin Gastroenterol Hepatol. 2011 Nov; 9(11):989-94.
    View in: PubMed
    Score: 0.023
  96. Gaps in the achievement of effectiveness of HCV treatment in national VA practice. J Hepatol. 2012 Feb; 56(2):320-5.
    View in: PubMed
    Score: 0.023
  97. The influence of age, sex, and race on the incidence of esophageal cancer in the United States (1992-2006). Scand J Gastroenterol. 2011 May; 46(5):597-602.
    View in: PubMed
    Score: 0.022
  98. Effectiveness of AFP and ultrasound tests on hepatocellular carcinoma mortality in HCV-infected patients in the USA. Gut. 2011 Jul; 60(7):992-7.
    View in: PubMed
    Score: 0.022
  99. Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States. Ann Intern Med. 2011 Jan 18; 154(2):85-93.
    View in: PubMed
    Score: 0.022
  100. Dietary history and physical activity and risk of advanced liver disease in veterans with chronic hepatitis C infection. Dig Dis Sci. 2011 Jun; 56(6):1835-47.
    View in: PubMed
    Score: 0.022
  101. Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection. Gastroenterology. 2011 Apr; 140(4):1182-1188.e1.
    View in: PubMed
    Score: 0.022
  102. Meeting vaccination quality measures for hepatitis A and B virus in patients with chronic hepatitis C infection. Hepatology. 2011 Jan; 53(1):42-52.
    View in: PubMed
    Score: 0.022
  103. Importance of patient, provider, and facility predictors of hepatitis C virus treatment in veterans: a national study. Am J Gastroenterol. 2011 Mar; 106(3):483-91.
    View in: PubMed
    Score: 0.022
  104. Systematic review: the epidemiology of eosinophilic oesophagitis in adults. Aliment Pharmacol Ther. 2010 Sep; 32(6):712-9.
    View in: PubMed
    Score: 0.022
  105. Reducing referral delays in colorectal cancer diagnosis: is it about how you ask? Qual Saf Health Care. 2010 Oct; 19(5):e27.
    View in: PubMed
    Score: 0.022
  106. Trauma history and risk of the irritable bowel syndrome in women veterans. Aliment Pharmacol Ther. 2010 Aug; 32(4):551-61.
    View in: PubMed
    Score: 0.021
  107. Oral bisphosphonate prescriptions and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus. Dig Dis Sci. 2010 Dec; 55(12):3404-7.
    View in: PubMed
    Score: 0.021
  108. Underdiagnosis of Lynch syndrome involves more than family history criteria. Clin Gastroenterol Hepatol. 2010 Jun; 8(6):523-9.
    View in: PubMed
    Score: 0.021
  109. Medications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus. Gastroenterology. 2010 Jun; 138(7):2260-6.
    View in: PubMed
    Score: 0.021
  110. Statin therapy and serum transaminases among a cohort of HCV-infected veterans. Dig Dis Sci. 2010 Jan; 55(1):190-5.
    View in: PubMed
    Score: 0.021
  111. Irritable bowel syndrome symptoms and health related quality of life in female veterans. Aliment Pharmacol Ther. 2010 Jan 15; 31(2):261-73.
    View in: PubMed
    Score: 0.021
  112. The extent and determinants of prescribing and adherence with acid-reducing medications: a national claims database study. Am J Gastroenterol. 2009 Sep; 104(9):2161-7.
    View in: PubMed
    Score: 0.020
  113. The big burden of obesity. Gastrointest Endosc. 2009 Oct; 70(4):752-7.
    View in: PubMed
    Score: 0.020
  114. Missed opportunities to initiate endoscopic evaluation for colorectal cancer diagnosis. Am J Gastroenterol. 2009 Oct; 104(10):2543-54.
    View in: PubMed
    Score: 0.020
  115. The utility of evaluating low serum albumin gradient ascites in patients with cirrhosis. Am J Gastroenterol. 2009 Jun; 104(6):1401-5.
    View in: PubMed
    Score: 0.020
  116. Statins and the risk of colorectal carcinoma: a nested case-control study in veterans with diabetes. Am J Gastroenterol. 2009 May; 104(5):1241-8.
    View in: PubMed
    Score: 0.020
  117. Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans. Hepatology. 2009 Jan; 49(1):116-23.
    View in: PubMed
    Score: 0.019
  118. Irritable bowel syndrome and dyspepsia among women veterans: prevalence and association with psychological distress. Aliment Pharmacol Ther. 2009 Jan; 29(1):115-25.
    View in: PubMed
    Score: 0.019
  119. Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis. J Hepatol. 2008 Nov; 49(5):831-44.
    View in: PubMed
    Score: 0.019
  120. Lagtimes in diagnosis and treatment of colorectal cancer: determinants and association with cancer stage and survival. Aliment Pharmacol Ther. 2008 Nov 01; 28(9):1166-74.
    View in: PubMed
    Score: 0.019
  121. The use of acid-decreasing medication in veteran patients with gastro-oesophageal reflux disorder with and without Barrett's oesophagus. Aliment Pharmacol Ther. 2008 Jun; 27(12):1293-9.
    View in: PubMed
    Score: 0.018
  122. Human immunodeficiency virus-associated squamous cell cancer of the anus: epidemiology and outcomes in the highly active antiretroviral therapy era. J Clin Oncol. 2008 Jan 20; 26(3):474-9.
    View in: PubMed
    Score: 0.018
  123. The validity of viral hepatitis and chronic liver disease diagnoses in Veterans Affairs administrative databases. Aliment Pharmacol Ther. 2008 Feb 01; 27(3):274-82.
    View in: PubMed
    Score: 0.018
  124. Epidemiology of hepatocellular carcinoma in Hispanics in the United States. Arch Intern Med. 2007 Oct 08; 167(18):1983-9.
    View in: PubMed
    Score: 0.018
  125. Prevalence and determinants of histological abnormalities of the gastric cardia in volunteers. Scand J Gastroenterol. 2007 Oct; 42(10):1158-66.
    View in: PubMed
    Score: 0.018
  126. Secular trends in the use, quality, and outcomes of gastrectomy for noncardia gastric cancer in the United States. Ann Surg Oncol. 2007 Sep; 14(9):2519-27.
    View in: PubMed
    Score: 0.018
  127. Temporal trends in new and recurrent oesophageal strictures in a Medicare population. Aliment Pharmacol Ther. 2007 May 15; 25(10):1223-9.
    View in: PubMed
    Score: 0.017
  128. The impact of curative intent surgery on the survival of pancreatic cancer patients: a U.S. Population-based study. Am J Gastroenterol. 2007 Jul; 102(7):1377-82.
    View in: PubMed
    Score: 0.017
  129. Obesity increases oesophageal acid exposure. Gut. 2007 Jun; 56(6):749-55.
    View in: PubMed
    Score: 0.017
  130. The use of screening colonoscopy for patients cared for by the Department of Veterans Affairs. Arch Intern Med. 2006 Nov 13; 166(20):2202-8.
    View in: PubMed
    Score: 0.017
  131. Noncardia gastric adenocarcinoma remains an important and deadly cancer in the United States: secular trends in incidence and survival. Am J Gastroenterol. 2006 Nov; 101(11):2485-92.
    View in: PubMed
    Score: 0.017
  132. Anthropometric correlates of intragastric pressure. Scand J Gastroenterol. 2006 Aug; 41(8):887-91.
    View in: PubMed
    Score: 0.016
  133. The epidemiology of pancreatic cancer in the United States: changes below the surface. Aliment Pharmacol Ther. 2006 Jul 01; 24(1):87-94.
    View in: PubMed
    Score: 0.016
  134. Is genomic evaluation feasible in endoscopic studies of Barrett's esophagus? A pilot study. Gastrointest Endosc. 2006 Jul; 64(1):17-26.
    View in: PubMed
    Score: 0.016
  135. Temporal trends in new and recurrent esophageal strictures in Department of Veterans Affairs. Am J Gastroenterol. 2006 Aug; 101(8):1727-33.
    View in: PubMed
    Score: 0.016
  136. A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States. Cancer Epidemiol Biomarkers Prev. 2006 Jun; 15(6):1198-203.
    View in: PubMed
    Score: 0.016
  137. Is there a race-based disparity in the survival of veterans with HIV? J Gen Intern Med. 2006 Jun; 21(6):613-7.
    View in: PubMed
    Score: 0.016
  138. Racial differences in survival of hepatocellular carcinoma in the United States: a population-based study. Clin Gastroenterol Hepatol. 2006 Jan; 4(1):104-10; quiz 4-5.
    View in: PubMed
    Score: 0.016
  139. Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study. J Hepatol. 2006 Jan; 44(1):158-66.
    View in: PubMed
    Score: 0.016
  140. Abdominal obesity and the risk of Barrett's esophagus. Am J Gastroenterol. 2005 Oct; 100(10):2151-6.
    View in: PubMed
    Score: 0.016
  141. Physical and psychosocial contributors to quality of life in veterans with hepatitis C not on antiviral therapy. J Clin Gastroenterol. 2005 Sep; 39(8):731-6.
    View in: PubMed
    Score: 0.015
  142. Postoperative 30-day mortality following surgical resection for colorectal cancer in veterans: changes in the right direction. Dig Dis Sci. 2005 Sep; 50(9):1722-8.
    View in: PubMed
    Score: 0.015
  143. Obesity is an independent risk factor for GERD symptoms and erosive esophagitis. Am J Gastroenterol. 2005 Jun; 100(6):1243-50.
    View in: PubMed
    Score: 0.015
  144. Fundoplication and the risk of esophageal cancer in gastroesophageal reflux disease: a Veterans Affairs cohort study. Am J Gastroenterol. 2005 May; 100(5):1002-8.
    View in: PubMed
    Score: 0.015
  145. Impact of an Electronic Medical Record Quality Improvement Intervention on Helicobacter pylori Treatment and Eradication Rates in a U.S. Hospital System. Helicobacter. 2025 Mar-Apr; 30(2):e70034.
    View in: PubMed
    Score: 0.015
  146. Dairy Consumption and the Colonic Mucosa-Associated Gut Microbiota in Humans-A Preliminary Investigation. Nutrients. 2025 Feb 02; 17(3).
    View in: PubMed
    Score: 0.015
  147. Utility of a depression score to predict candidacy for hepatitis C virus therapy in veterans: a prospective longitudinal study. Aliment Pharmacol Ther. 2005 Feb 01; 21(3):235-42.
    View in: PubMed
    Score: 0.015
  148. Survival in hepatitis C and HIV co-infection: a cohort study of hospitalized veterans. Clin Gastroenterol Hepatol. 2005 Feb; 3(2):175-83.
    View in: PubMed
    Score: 0.015
  149. Dietary intake and the risk of gastro-oesophageal reflux disease: a cross sectional study in volunteers. Gut. 2005 Jan; 54(1):11-7.
    View in: PubMed
    Score: 0.015
  150. Increased use of low anterior resection for veterans with rectal cancer. Aliment Pharmacol Ther. 2005 Jan 01; 21(1):35-41.
    View in: PubMed
    Score: 0.015
  151. The effect of HIV coinfection on the risk of cirrhosis and hepatocellular carcinoma in U.S. veterans with hepatitis C. Am J Gastroenterol. 2005 Jan; 100(1):56-63.
    View in: PubMed
    Score: 0.015
  152. The epidemiology of malignant gastrointestinal stromal tumors: an analysis of 1,458 cases from 1992 to 2000. Am J Gastroenterol. 2005 Jan; 100(1):162-8.
    View in: PubMed
    Score: 0.015
  153. Prevalence and Outcomes of Emergency Presentations of Colorectal Cancer in Veterans Affairs Health Care System. Dig Dis Sci. 2025 Jan; 70(1):177-190.
    View in: PubMed
    Score: 0.015
  154. Interval Advanced Adenomas and Neoplasia in Patients with Negative Colonoscopy Following Positive Stool-Based Colorectal Cancer Screening Test. Dig Dis Sci. 2025 Jan; 70(1):350-359.
    View in: PubMed
    Score: 0.015
  155. Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: a cohort study, 1992-2001. Arch Intern Med. 2004 Nov 22; 164(21):2349-54.
    View in: PubMed
    Score: 0.015
  156. Phase 3 Validation of PAaM for Hepatocellular Carcinoma Risk Stratification in Cirrhosis. Gastroenterology. 2025 Mar; 168(3):556-567.e7.
    View in: PubMed
    Score: 0.015
  157. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology. 2004 Nov; 127(5 Suppl 1):S27-34.
    View in: PubMed
    Score: 0.015
  158. The prevalence and risk factors of functional dyspepsia in a multiethnic population in the United States. Am J Gastroenterol. 2004 Nov; 99(11):2210-6.
    View in: PubMed
    Score: 0.015
  159. GLP-1 Receptor Agonists and Risk for Cirrhosis and Related Complications in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease. JAMA Intern Med. 2024 Nov 01; 184(11):1314-1323.
    View in: PubMed
    Score: 0.015
  160. Neighborhood-level deprivation mediates racial and ethnic disparities in HCC diagnosis in Texas. Hepatol Commun. 2024 Nov 01; 8(11).
    View in: PubMed
    Score: 0.015
  161. Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus. Am J Gastroenterol. 2004 Oct; 99(10):1877-83.
    View in: PubMed
    Score: 0.015
  162. Psychosocial factors are the most common contraindications for antiviral therapy at initial evaluation in veterans with chronic hepatitis C. J Clin Gastroenterol. 2004 Jul; 38(6):530-4.
    View in: PubMed
    Score: 0.014
  163. The length of newly diagnosed Barrett's oesophagus and prior use of acid suppressive therapy. Aliment Pharmacol Ther. 2004 Jun 15; 19(12):1255-60.
    View in: PubMed
    Score: 0.014
  164. Gastroesophageal reflux among different racial groups in the United States. Gastroenterology. 2004 Jun; 126(7):1692-9.
    View in: PubMed
    Score: 0.014
  165. Is the length of newly diagnosed Barrett's esophagus decreasing? The experience of a VA Health Care System. Clin Gastroenterol Hepatol. 2004 Apr; 2(4):296-300.
    View in: PubMed
    Score: 0.014
  166. Surgical volume and long-term survival following surgery for colorectal cancer in the Veterans Affairs Health-Care System. Am J Gastroenterol. 2004 Apr; 99(4):668-75.
    View in: PubMed
    Score: 0.014
  167. Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study. Hepatology. 2004 Mar; 39(3):798-803.
    View in: PubMed
    Score: 0.014
  168. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol. 2004 Mar; 40(3):472-7.
    View in: PubMed
    Score: 0.014
  169. Genome-wide association study identifies high-impact susceptibility loci for HCC in North America. Hepatology. 2024 07 01; 80(1):87-101.
    View in: PubMed
    Score: 0.014
  170. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology. 2004 Feb; 126(2):460-8.
    View in: PubMed
    Score: 0.014
  171. Recent Trends in the Incidence of Gastric Cancer in the United States. J Clin Gastroenterol. 2024 01 01; 58(1):39-45.
    View in: PubMed
    Score: 0.014
  172. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med. 2003 Nov 18; 139(10):817-23.
    View in: PubMed
    Score: 0.014
  173. Temporal trends (1973-1997) in survival of patients with esophageal adenocarcinoma in the United States: a glimmer of hope? Am J Gastroenterol. 2003 Jul; 98(7):1627-33.
    View in: PubMed
    Score: 0.013
  174. Is there a true "shift" to the right colon in the incidence of colorectal cancer? Am J Gastroenterol. 2003 Jun; 98(6):1400-9.
    View in: PubMed
    Score: 0.013
  175. Meta-analysis: proton pump inhibitor or H2-receptor antagonist for Helicobacter pylori eradication. Aliment Pharmacol Ther. 2003 May 15; 17(10):1229-36.
    View in: PubMed
    Score: 0.013
  176. Survival of colorectal cancer patients hospitalized in the Veterans Affairs Health Care System. Am J Gastroenterol. 2003 May; 98(5):1186-92.
    View in: PubMed
    Score: 0.013
  177. Geographic variation within the United States in the incidence of hepatocellular carcinoma. J Clin Epidemiol. 2003 May; 56(5):487-93.
    View in: PubMed
    Score: 0.013
  178. Association between hepatitis C infection and other infectious diseases: a case for targeted screening? Am J Gastroenterol. 2003 Jan; 98(1):167-74.
    View in: PubMed
    Score: 0.013
  179. Extrahepatic manifestations of hepatitis C among United States male veterans. Hepatology. 2002 Dec; 36(6):1439-45.
    View in: PubMed
    Score: 0.013
  180. Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroenterol. 2002 Nov-Dec; 35(5 Suppl 2):S72-8.
    View in: PubMed
    Score: 0.013
  181. Synergistic Associations of PNPLA3 I148M Variant, Alcohol Intake, and Obesity With Risk of Cirrhosis, Hepatocellular Carcinoma, and Mortality. JAMA Netw Open. 2022 10 03; 5(10):e2234221.
    View in: PubMed
    Score: 0.013
  182. Rising prevalence of hepatitis C virus infection among patients recently diagnosed with hepatocellular carcinoma in the United States. J Clin Gastroenterol. 2002 Sep; 35(3):266-9.
    View in: PubMed
    Score: 0.013
  183. Neighborhood-Level Factors Contribute to Disparities in Hepatocellular Carcinoma Incidence in Texas. Clin Gastroenterol Hepatol. 2023 05; 21(5):1314-1322.e5.
    View in: PubMed
    Score: 0.012
  184. Psychiatric disorders among veterans with hepatitis C infection. Gastroenterology. 2002 Aug; 123(2):476-82.
    View in: PubMed
    Score: 0.012
  185. Risk factors for the severity of erosive esophagitis in Helicobacter pylori-negative patients with gastroesophageal reflux disease. Scand J Gastroenterol. 2002 Aug; 37(8):899-904.
    View in: PubMed
    Score: 0.012
  186. Burden of liver disease in the United States: summary of a workshop. Hepatology. 2002 Jul; 36(1):227-42.
    View in: PubMed
    Score: 0.012
  187. Admixture Mapping in African Americans Identifies New Risk Loci for HCV-Related Cirrhosis. Clin Gastroenterol Hepatol. 2023 04; 21(4):1023-1030.e39.
    View in: PubMed
    Score: 0.012
  188. Diabetes increases the risk of acute hepatic failure. Gastroenterology. 2002 Jun; 122(7):1822-8.
    View in: PubMed
    Score: 0.012
  189. Perceptions of weight status and energy balance behaviors among patients with non-alcoholic fatty liver disease. Sci Rep. 2022 04 05; 12(1):5695.
    View in: PubMed
    Score: 0.012
  190. Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA. Gut. 2002 Mar; 50(3):368-72.
    View in: PubMed
    Score: 0.012
  191. Race/Ethnicity and Birthplace as Risk Factors for Gastric Intestinal Metaplasia in a Multiethnic United States Population. Am J Gastroenterol. 2022 02 01; 117(2):280-287.
    View in: PubMed
    Score: 0.012
  192. GALAD demonstrates high sensitivity for HCC surveillance in a cohort of patients with cirrhosis. Hepatology. 2022 03; 75(3):541-549.
    View in: PubMed
    Score: 0.012
  193. Alcohol consumption and the risk of gastric intestinal metaplasia in a U.S. Veterans population. PLoS One. 2021; 16(11):e0260019.
    View in: PubMed
    Score: 0.012
  194. Comparative performance of risk prediction models for hepatitis B-related hepatocellular carcinoma in the United States. J Hepatol. 2022 02; 76(2):294-301.
    View in: PubMed
    Score: 0.012
  195. The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans. Am J Gastroenterol. 2001 Aug; 96(8):2462-7.
    View in: PubMed
    Score: 0.012
  196. Gastroesophageal reflux disease is a risk factor for laryngeal and pharyngeal cancer. Am J Gastroenterol. 2001 Jul; 96(7):2013-8.
    View in: PubMed
    Score: 0.012
  197. Risk factors for the development of renal dysfunction in hospitalized patients with cirrhosis. Am J Gastroenterol. 2001 Jul; 96(7):2206-10.
    View in: PubMed
    Score: 0.012
  198. Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial. Am J Gastroenterol. 2001 Apr; 96(4):979-83.
    View in: PubMed
    Score: 0.011
  199. A Novel Biomarker Panel for the Early Detection and Risk Assessment of Hepatocellular Carcinoma in Patients with Cirrhosis. Cancer Prev Res (Phila). 2021 06; 14(6):667-674.
    View in: PubMed
    Score: 0.011
  200. Epidemiology of hepatocellular carcinoma. Clin Liver Dis. 2001 Feb; 5(1):87-107, vi.
    View in: PubMed
    Score: 0.011
  201. Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States. Hepatology. 2001 Jan; 33(1):62-5.
    View in: PubMed
    Score: 0.011
  202. Improved survival after variceal hemorrhage over an 11-year period in the Department of Veterans Affairs. Am J Gastroenterol. 2000 Dec; 95(12):3566-73.
    View in: PubMed
    Score: 0.011
  203. Risk factors for the rising rates of primary liver cancer in the United States. Arch Intern Med. 2000 Nov 27; 160(21):3227-30.
    View in: PubMed
    Score: 0.011
  204. Development, Validation, and Evaluation of a Simple Machine Learning Model to Predict Cirrhosis Mortality. JAMA Netw Open. 2020 11 02; 3(11):e2023780.
    View in: PubMed
    Score: 0.011
  205. Risk of Cirrhosis and Hepatocellular Cancer in Patients With NAFLD and Normal Liver Enzymes. Hepatology. 2020 10; 72(4):1242-1252.
    View in: PubMed
    Score: 0.011
  206. Oral Health and the Altered Colonic Mucosa-Associated Gut Microbiota. Dig Dis Sci. 2021 09; 66(9):2981-2991.
    View in: PubMed
    Score: 0.011
  207. Alcohol use alters the colonic mucosa-associated gut microbiota in humans. Nutr Res. 2020 11; 83:119-128.
    View in: PubMed
    Score: 0.011
  208. The Incidence and Prevalence of Anxiety, Depression, and Post-traumatic Stress Disorder in a National Cohort of US Veterans With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2020 08 20; 26(9):1423-1428.
    View in: PubMed
    Score: 0.011
  209. External Validation of Four Point-of-Care Noninvasive Scores for Predicting Advanced Hepatic Fibrosis in a Predominantly Hispanic NAFLD Population. Dig Dis Sci. 2021 07; 66(7):2387-2393.
    View in: PubMed
    Score: 0.011
  210. Dietary Factors and Gastric Intestinal Metaplasia Risk Among US Veterans. Dig Dis Sci. 2021 05; 66(5):1600-1610.
    View in: PubMed
    Score: 0.011
  211. Model for end-stage liver disease-sodium underestimates 90-day mortality risk in patients with acute-on-chronic liver failure. J Hepatol. 2020 12; 73(6):1425-1433.
    View in: PubMed
    Score: 0.011
  212. Gastric microbiota and Helicobacter pylori in Indonesian population. Helicobacter. 2020 Aug; 25(4):e12695.
    View in: PubMed
    Score: 0.011
  213. Women Have a Lower Risk of Nonalcoholic Fatty Liver Disease but a Higher Risk of Progression vs Men: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2021 01; 19(1):61-71.e15.
    View in: PubMed
    Score: 0.011
  214. Demographic and Lifestyle Risk Factors for Gastric Intestinal Metaplasia Among US Veterans. Am J Gastroenterol. 2020 03; 115(3):381-387.
    View in: PubMed
    Score: 0.011
  215. Effectiveness of Elbasvir/Grazoprevir in patients with hepatitis C virus genotype 1 infection and chronic kidney disease in the United States veterans population. Antiviral Res. 2020 02; 174:104698.
    View in: PubMed
    Score: 0.010
  216. Use of Acid-Suppressant Medications After Diagnosis Increases Mortality in a Subset of Gastrointestinal Cancer Patients. Dig Dis Sci. 2020 09; 65(9):2691-2699.
    View in: PubMed
    Score: 0.010
  217. Prevalence of Helicobacter pylori Positive Non-cardia Gastric Adenocarcinoma Is Low and Decreasing in a US Population. Dig Dis Sci. 2020 08; 65(8):2403-2411.
    View in: PubMed
    Score: 0.010
  218. Sex and Race Disparities in the Incidence of Hepatocellular Carcinoma in the United States Examined through Age-Period-Cohort Analysis. Cancer Epidemiol Biomarkers Prev. 2020 01; 29(1):88-94.
    View in: PubMed
    Score: 0.010
  219. Dietary quality and the colonic mucosa-associated gut microbiome in humans. Am J Clin Nutr. 2019 09 01; 110(3):701-712.
    View in: PubMed
    Score: 0.010
  220. Corpus gastritis is protective against reflux oesophagitis. Gut. 1999 Aug; 45(2):181-5.
    View in: PubMed
    Score: 0.010
  221. Outcome of erosive reflux esophagitis after Nissen fundoplication. Am J Gastroenterol. 1999 Jul; 94(7):1771-6.
    View in: PubMed
    Score: 0.010
  222. Risk of Hepatocellular Cancer Recurrence in Hepatitis C Virus+ Patients Treated with Direct-Acting Antiviral Agents. Dig Dis Sci. 2019 11; 64(11):3328-3336.
    View in: PubMed
    Score: 0.010
  223. Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma. J Hepatol. 2019 07; 71(1):104-114.
    View in: PubMed
    Score: 0.010
  224. Awareness of chronic viral hepatitis in the United States: An update from the National Health and Nutrition Examination Survey. J Viral Hepat. 2019 05; 26(5):596-602.
    View in: PubMed
    Score: 0.010
  225. Dietary Nutrients Involved in One-Carbon Metabolism and Colonic Mucosa-Associated Gut Microbiome in Individuals with an Endoscopically Normal Colon. Nutrients. 2019 Mar 13; 11(3).
    View in: PubMed
    Score: 0.010
  226. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med. 1999 Mar 11; 340(10):745-50.
    View in: PubMed
    Score: 0.010
  227. Characteristics of intestinal metaplasia in the gastric cardia. Am J Gastroenterol. 1999 Mar; 94(3):622-7.
    View in: PubMed
    Score: 0.010
  228. A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal Women. Cancer Prev Res (Phila). 2019 04; 12(4):237-246.
    View in: PubMed
    Score: 0.010
  229. Carbamazepine-associated severe bile duct injury. Am J Gastroenterol. 1999 Feb; 94(2):526-7.
    View in: PubMed
    Score: 0.010
  230. Risk Trajectories for Readmission and Death After Cirrhosis-Related Hospitalization. Dig Dis Sci. 2019 06; 64(6):1470-1477.
    View in: PubMed
    Score: 0.010
  231. Prevalence and short-term mortality of acute-on-chronic liver failure: A national cohort study from the USA. J Hepatol. 2019 04; 70(4):639-647.
    View in: PubMed
    Score: 0.010
  232. Missed Opportunities for Screening and Surveillance of Barrett's Esophagus in Veterans with Esophageal Adenocarcinoma. Dig Dis Sci. 2019 02; 64(2):367-372.
    View in: PubMed
    Score: 0.010
  233. Prior Diagnosis of Barrett's Esophagus Is Infrequent, but Associated with Improved Esophageal Adenocarcinoma Survival. Dig Dis Sci. 2018 11; 63(11):3112-3119.
    View in: PubMed
    Score: 0.009
  234. Real-world effectiveness of elbasvir/grazoprevir In HCV-infected patients in the US veterans affairs healthcare system. J Viral Hepat. 2018 11; 25(11):1270-1279.
    View in: PubMed
    Score: 0.009
  235. Long-term follow up of patients with obscure gastrointestinal bleeding examined with video capsule endoscopy. Medicine (Baltimore). 2018 Jul; 97(29):e11429.
    View in: PubMed
    Score: 0.009
  236. Acid suppression medications reduce risk of oesophageal adenocarcinoma in Barrett's oesophagus: a nested case-control study in US male veterans. Aliment Pharmacol Ther. 2018 08; 48(4):469-477.
    View in: PubMed
    Score: 0.009
  237. The Association Between Statin Use After Diagnosis and Mortality Risk in Patients With Esophageal Cancer: A Retrospective Cohort Study of United States Veterans. Am J Gastroenterol. 2018 09; 113(9):1310.
    View in: PubMed
    Score: 0.009
  238. Factors Associated With Recurrence of Barrett's Esophagus After Radiofrequency Ablation. Clin Gastroenterol Hepatol. 2019 01; 17(1):65-72.e5.
    View in: PubMed
    Score: 0.009
  239. Helicobacter pylori Infection Is Associated With Reduced Risk of Barrett's Esophagus: An Analysis of the Barrett's and Esophageal Adenocarcinoma Consortium. Am J Gastroenterol. 2018 08; 113(8):1148-1155.
    View in: PubMed
    Score: 0.009
  240. Hepatitis B Virus Screening and Reactivation in a National VA Cohort of Patients with Inflammatory Bowel Disease Treated with Tumor Necrosis Factor Antagonists. Dig Dis Sci. 2018 06; 63(6):1551-1557.
    View in: PubMed
    Score: 0.009
  241. A prospective study of soluble receptor for advanced glycation end products and adipokines in association with pancreatic cancer in postmenopausal women. Cancer Med. 2018 05; 7(5):2180-2191.
    View in: PubMed
    Score: 0.009
  242. Development of a scoring system to predict hepatocellular carcinoma in Asians on antivirals for chronic hepatitis B. J Hepatol. 2018 08; 69(2):278-285.
    View in: PubMed
    Score: 0.009
  243. Determinants and Outcomes of Hospice Utilization Among Patients with Advance-Staged Hepatocellular Carcinoma in a Veteran Affairs Population. Dig Dis Sci. 2018 05; 63(5):1173-1181.
    View in: PubMed
    Score: 0.009
  244. Positive Predictive Value of International Classification of Diseases, 10th Revision, Codes for Cirrhosis and Its Related Complications. Clin Gastroenterol Hepatol. 2018 10; 16(10):1677-1678.
    View in: PubMed
    Score: 0.009
  245. Diagnostic Performance of Measurement of Fecal Elastase-1 in Detection of Exocrine Pancreatic Insufficiency: Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2018 08; 16(8):1220-1228.e4.
    View in: PubMed
    Score: 0.009
  246. Barriers to hepatitis C treatment in the era of direct-acting anti-viral agents. Aliment Pharmacol Ther. 2017 11; 46(10):992-1000.
    View in: PubMed
    Score: 0.009
  247. Sleep Duration and Risk of Liver Cancer in Postmenopausal Women: The Women's Health Initiative Study. J Womens Health (Larchmt). 2017 12; 26(12):1270-1277.
    View in: PubMed
    Score: 0.009
  248. Association Between Laparoscopic Antireflux Surgery and Recurrence of Gastroesophageal Reflux. JAMA. 2017 09 12; 318(10):939-946.
    View in: PubMed
    Score: 0.009
  249. Role of Age and Race in the Risk of Hepatocellular Carcinoma in Veterans With Hepatitis B Virus Infection. Clin Gastroenterol Hepatol. 2018 02; 16(2):252-259.
    View in: PubMed
    Score: 0.009
  250. Comorbid occurrence of laryngeal or pulmonary disease with esophagitis in United States military veterans. Gastroenterology. 1997 Sep; 113(3):755-60.
    View in: PubMed
    Score: 0.009
  251. Mycobacterium avium complex esophagitis. Am J Gastroenterol. 1997 Sep; 92(9):1561-3.
    View in: PubMed
    Score: 0.009
  252. Hepatitis C virus-related complications are increasing in women veterans: A national cohort study. J Viral Hepat. 2017 11; 24(11):955-965.
    View in: PubMed
    Score: 0.009
  253. Polymorphisms of 5-HTT LPR and GN?3 825C>T and Response to Antidepressant Treatment in Functional Dyspepsia: A Study from The Functional Dyspepsia Treatment Trial. Am J Gastroenterol. 2017 Jun; 112(6):903-909.
    View in: PubMed
    Score: 0.009
  254. Risk of oesophageal adenocarcinoma in individuals with Barrett's oesophagus. Eur J Cancer. 2017 04; 75:41-46.
    View in: PubMed
    Score: 0.009
  255. Tuberculosis Screening and Reactivation Among a National Cohort of Patients with Inflammatory Bowel Disease Treated with Tumor Necrosis Factor Alpha Antagonists. Inflamm Bowel Dis. 2017 02; 23(2):254-260.
    View in: PubMed
    Score: 0.009
  256. Menopausal hormone therapy and the risk of esophageal and gastric cancer. Int J Cancer. 2017 04 01; 140(7):1693-1699.
    View in: PubMed
    Score: 0.008
  257. Association of esophagitis and esophageal strictures with diseases treated with nonsteroidal anti-inflammatory drugs. Am J Gastroenterol. 1997 Jan; 92(1):52-6.
    View in: PubMed
    Score: 0.008
  258. Risk Profiles for Barrett's Esophagus Differ between New and Prevalent, and Long- and Short-Segment Cases. PLoS One. 2016; 11(12):e0169250.
    View in: PubMed
    Score: 0.008
  259. Determinants of Healthcare Utilization Among Veterans with Inflammatory Bowel Disease. Dig Dis Sci. 2017 03; 62(3):607-614.
    View in: PubMed
    Score: 0.008
  260. Shiftwork Is Not Associated with Increased Risk of NAFLD: Findings from the National Health and Nutrition Examination Survey. Dig Dis Sci. 2017 02; 62(2):526-533.
    View in: PubMed
    Score: 0.008
  261. Acculturation and Nonalcoholic Fatty Liver Disease Risk Among Hispanics of Mexican Origin: Findings From the National Health and Nutrition Examination Survey. Clin Gastroenterol Hepatol. 2017 02; 15(2):310-312.
    View in: PubMed
    Score: 0.008
  262. Hepatocellular carcinoma in the absence of cirrhosis in patients with chronic hepatitis B virus infection. J Hepatol. 2017 02; 66(2):355-362.
    View in: PubMed
    Score: 0.008
  263. Risk and Predictors of Variceal Bleeding in Cirrhosis Patients Receiving Primary Prophylaxis With Non-Selective Beta-Blockers. Am J Gastroenterol. 2016 12; 111(12):1778-1787.
    View in: PubMed
    Score: 0.008
  264. Role of Non-hepatic Medical Comorbidity and Functional Limitations in Predicting Mortality in Patients with HCV. Dig Dis Sci. 2017 01; 62(1):76-83.
    View in: PubMed
    Score: 0.008
  265. Nonsteroidal Anti-Inflammatory Drug Use is Not Associated With Reduced Risk of Barrett's Esophagus. Am J Gastroenterol. 2016 11; 111(11):1528-1535.
    View in: PubMed
    Score: 0.008
  266. Medical comorbidity and distress in patients with irritable bowel syndrome: The moderating role of age. J Psychosom Res. 2016 09; 88:48-53.
    View in: PubMed
    Score: 0.008
  267. Inverse Association Between Gluteofemoral Obesity and Risk of?Barrett's Esophagus in a Pooled Analysis. Clin Gastroenterol Hepatol. 2016 10; 14(10):1412-1419.e3.
    View in: PubMed
    Score: 0.008
  268. Race and Gender Differences in the Use of Direct Acting Antiviral Agents for Hepatitis C Virus. Clin Infect Dis. 2016 08 01; 63(3):291-9.
    View in: PubMed
    Score: 0.008
  269. A prospective study of soluble receptor for advanced glycation end-products and colorectal cancer risk in postmenopausal women. Cancer Epidemiol. 2016 06; 42:115-23.
    View in: PubMed
    Score: 0.008
  270. Patient-Reported Attributions for Missed Colonoscopy Appointments in Two Large Healthcare Systems. Dig Dis Sci. 2016 07; 61(7):1853-61.
    View in: PubMed
    Score: 0.008
  271. Validation of Case Finding Algorithms for Hepatocellular Cancer From Administrative Data and Electronic Health Records Using Natural Language Processing. Med Care. 2016 Feb; 54(2):e9-14.
    View in: PubMed
    Score: 0.008
  272. Cirrhosis is under-recognised in patients subsequently diagnosed with hepatocellular cancer. Aliment Pharmacol Ther. 2016 Mar; 43(5):621-30.
    View in: PubMed
    Score: 0.008
  273. Statins Are Underutilized in Patients with Nonalcoholic Fatty Liver Disease and Dyslipidemia. Dig Dis Sci. 2016 06; 61(6):1714-20.
    View in: PubMed
    Score: 0.008
  274. Coffee or Tea, Hot or Cold, Are Not Associated With Risk of Barrett's Esophagus. Clin Gastroenterol Hepatol. 2016 May; 14(5):769-72.
    View in: PubMed
    Score: 0.008
  275. Premature Birth and Large for Gestational Age Are Associated with Risk of Barrett's Esophagus in Adults. Dig Dis Sci. 2016 Apr; 61(4):1139-47.
    View in: PubMed
    Score: 0.008
  276. Transarterial bland versus chemoembolization for hepatocellular carcinoma: rethinking a gold standard. J Surg Res. 2016 Feb; 200(2):552-9.
    View in: PubMed
    Score: 0.008
  277. Esophageal adenocarcinoma after obesity surgery in a population-based cohort study. Surg Obes Relat Dis. 2017 Jan; 13(1):28-34.
    View in: PubMed
    Score: 0.008
  278. Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans is Associated With Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. 2016 Jan; 14(1):124-31.e1.
    View in: PubMed
    Score: 0.008
  279. Effect of Amitriptyline and Escitalopram on Functional Dyspepsia: A Multicenter, Randomized Controlled Study. Gastroenterology. 2015 Aug; 149(2):340-9.e2.
    View in: PubMed
    Score: 0.008
  280. Obesity Early in Adulthood Increases Risk but Does Not Affect Outcomes of Hepatocellular Carcinoma. Gastroenterology. 2015 Jul; 149(1):119-29.
    View in: PubMed
    Score: 0.008
  281. Physical activity and the risk of Barrett's esophagus. Dis Esophagus. 2016 Apr; 29(3):248-54.
    View in: PubMed
    Score: 0.007
  282. Antibiotic Resistance of Helicobacter pylori Among Male United States Veterans. Clin Gastroenterol Hepatol. 2015 Sep; 13(9):1616-24.
    View in: PubMed
    Score: 0.007
  283. Clinical outcomes of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients. Hepatology. 2014 Dec; 60(6):1871-8.
    View in: PubMed
    Score: 0.007
  284. Secular trends in the incidence of cholangiocarcinoma in the USA and the impact of misclassification. Dig Dis Sci. 2014 Dec; 59(12):3103-10.
    View in: PubMed
    Score: 0.007
  285. Nonalcoholic fatty liver disease (NAFLD) in the Veterans Administration population: development and validation of an algorithm for NAFLD using automated data. Aliment Pharmacol Ther. 2014 Oct; 40(8):949-54.
    View in: PubMed
    Score: 0.007
  286. Temporal trends of nonalcoholic fatty liver disease-related hepatocellular carcinoma in the veteran affairs population. Clin Gastroenterol Hepatol. 2015 Mar; 13(3):594-601.e1.
    View in: PubMed
    Score: 0.007
  287. The quality of care provided to patients with varices in the department of Veterans Affairs. Am J Gastroenterol. 2014 Jul; 109(7):934-40.
    View in: PubMed
    Score: 0.007
  288. Clinical and psychosocial variables associated with behavioral intentions to undergo surveillance endoscopy. BMC Gastroenterol. 2014 Jun 10; 14:107.
    View in: PubMed
    Score: 0.007
  289. Nonalcoholic fatty liver disease is underrecognized in the primary care setting. Am J Gastroenterol. 2015 Jan; 110(1):10-4.
    View in: PubMed
    Score: 0.007
  290. Accuracy of diagnostic codes for identifying patients with ulcerative colitis and Crohn's disease in the Veterans Affairs Health Care System. Dig Dis Sci. 2014 Oct; 59(10):2406-10.
    View in: PubMed
    Score: 0.007
  291. Fat mass by bioelectrical impedance analysis is not associated with increased risk of Barrett esophagus. J Clin Gastroenterol. 2014 Mar; 48(3):218-23.
    View in: PubMed
    Score: 0.007
  292. Patient experiences with surveillance endoscopy: a qualitative study. Dig Dis Sci. 2014 Jul; 59(7):1378-85.
    View in: PubMed
    Score: 0.007
  293. The impact of hepatitis C burden: an evidence-based approach. Aliment Pharmacol Ther. 2014 Mar; 39(5):518-31.
    View in: PubMed
    Score: 0.007
  294. WNT signaling pathway gene polymorphisms and risk of hepatic fibrosis and inflammation in HCV-infected patients. PLoS One. 2013; 8(12):e84407.
    View in: PubMed
    Score: 0.007
  295. The impact of HIV viral control on the incidence of HIV-associated anal cancer. J Acquir Immune Defic Syndr. 2013 Aug 15; 63(5):631-8.
    View in: PubMed
    Score: 0.007
  296. Association between facility characteristics and the process of care delivered to patients with hepatitis C virus infection. Dig Dis Sci. 2014 Feb; 59(2):273-81.
    View in: PubMed
    Score: 0.007
  297. Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: risk and prognosis prediction. Mol Carcinog. 2013 Nov; 52 Suppl 1:E139-47.
    View in: PubMed
    Score: 0.007
  298. Choosing Wisely and the perceived drivers of endoscopy use. Clin Gastroenterol Hepatol. 2013 Jul; 11(7):753-5.
    View in: PubMed
    Score: 0.007
  299. Esophageal eosinophilia after radiofrequency ablation for Barrett's esophagus. Dis Esophagus. 2013 Sep-Oct; 26(7):674-7.
    View in: PubMed
    Score: 0.006
  300. Incidence and survival of colorectal cancer among Hispanics in the United States: a population-based study. Dig Dis Sci. 2013 Jul; 58(7):2052-60.
    View in: PubMed
    Score: 0.006
  301. Process of care for hepatitis C infection is linked to treatment outcome and virologic response. Clin Gastroenterol Hepatol. 2012 Nov; 10(11):1270-1277.e3.
    View in: PubMed
    Score: 0.006
  302. The performance of process measures in hepatitis C. Am J Gastroenterol. 2012 Oct; 107(10):1512-21.
    View in: PubMed
    Score: 0.006
  303. Gallstones and cholecystectomy in relation to risk of intra- and extrahepatic cholangiocarcinoma. Br J Cancer. 2012 Feb 28; 106(5):1011-5.
    View in: PubMed
    Score: 0.006
  304. Increased risk of hepatocellular carcinoma after cholecystectomy. Br J Cancer. 2011 Jun 28; 105(1):154-6.
    View in: PubMed
    Score: 0.006
  305. Insurance status and treatment candidacy of hepatitis C patients: analysis of population-based data from the United States. Hepatology. 2011 Mar; 53(3):737-45.
    View in: PubMed
    Score: 0.006
  306. Overview of the viral hepatitis problem. J Fam Pract. 2010 Apr; 59(4 Suppl):S11-6.
    View in: PubMed
    Score: 0.005
  307. Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression. Gastroenterology. 2010 Feb; 138(2):513-21, 521.e1-6.
    View in: PubMed
    Score: 0.005
  308. Medication usage and the risk of neoplasia in patients with Barrett's esophagus. Clin Gastroenterol Hepatol. 2009 Dec; 7(12):1299-304.
    View in: PubMed
    Score: 0.005
  309. Using a multifaceted approach to improve the follow-up of positive fecal occult blood test results. Am J Gastroenterol. 2009 Apr; 104(4):942-52.
    View in: PubMed
    Score: 0.005
  310. Racial disparities in utilization of liver transplantation for hepatocellular carcinoma in the United States, 1998-2002. Am J Gastroenterol. 2008 Jan; 103(1):120-7.
    View in: PubMed
    Score: 0.005
  311. Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. JAMA. 2007 May 09; 297(18):2010-7.
    View in: PubMed
    Score: 0.004
  312. Screening for hepatocellular carcinoma among veterans with hepatitis C on disease stage, treatment received, and survival. Clin Gastroenterol Hepatol. 2007 Apr; 5(4):508-12.
    View in: PubMed
    Score: 0.004
  313. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study. Am J Gastroenterol. 2007 May; 102(5):1016-21.
    View in: PubMed
    Score: 0.004
  314. Adapting the Rx-Risk-V for mortality prediction in outpatient populations. Med Care. 2006 Aug; 44(8):793-7.
    View in: PubMed
    Score: 0.004
  315. Obesity: a challenge to esophagogastric junction integrity. Gastroenterology. 2006 Mar; 130(3):639-49.
    View in: PubMed
    Score: 0.004
  316. The association of body mass index with Barrett's oesophagus. Aliment Pharmacol Ther. 2005 Nov 15; 22(10):1005-10.
    View in: PubMed
    Score: 0.004
  317. Evaluation for liver transplantation: adherence to AASLD referral guidelines in a large Veterans Affairs center. Liver Transpl. 2005 Nov; 11(11):1370-8.
    View in: PubMed
    Score: 0.004
  318. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2005 May; 54(5):710-7.
    View in: PubMed
    Score: 0.004
  319. The impact of immigration on the increasing incidence of hepatocellular carcinoma in the United States. Aliment Pharmacol Ther. 2004 Aug 15; 20(4):445-50.
    View in: PubMed
    Score: 0.004
  320. Serum ferritin level predicts advanced hepatic fibrosis among U.S. patients with phenotypic hemochromatosis. Ann Intern Med. 2003 Apr 15; 138(8):627-33.
    View in: PubMed
    Score: 0.003
  321. The role of hepatitis C in hepatocellular carcinoma: a case control study among Egyptian patients. J Clin Gastroenterol. 2001 Aug; 33(2):123-6.
    View in: PubMed
    Score: 0.003
  322. Celiac sprue among US military veterans: associated disorders and clinical manifestations. Dig Dis Sci. 1999 May; 44(5):966-72.
    View in: PubMed
    Score: 0.002
  323. Colonic mucosal abnormalities associated with oral sodium phosphate solution. Gastrointest Endosc. 1996 May; 43(5):463-6.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.